Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery

Completed · Phase 4

Conditions studied: Anesthesia, Local

In brief

This is a randomized, single blinded clinical trial whose purpose is to assess the impact of liposomal bupivacaine (LB) in a single shot interscalene nerve block compared with standard bupivacaine (same dose) in a single shot interscalene nerve block in terms of postoperative pain control. Specifically, outpatient pain scores,use of postoperative pain medicine and patient-reported functional outcomes after shoulder arthroplasty surgery will be evaluated.

Key facts

Study ID

NCT04180943

Run by

Bassett Healthcare

People needed

85

Starts

2019-12-13

Expected to finish

2021-06-01

Last updated by the study team

2022-03-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients aged 18 years or older
• undergoing shoulder arthroscopy or arthroplasty
• must meet the criteria for standard of care of ambulatory surgery patients per anesthesia guidelines issued by the American Society of Anesthesiologists

You may not qualify if…

• contraindications to regional anesthesia,
• allergy to any component of multimodal analgesia
• history of opioid use of >50 morphine milligram equivalents (MME) daily,
• significant peripheral neuropathy or neurologic disorder affecting the upper extremity,
• cognitive or psychiatric condition that might affect the patient?s assessment or inability to provide informed consent
• pregnancy (this is an exclusion for surgery as well)

Where it is running

• Bassett Healthcare Network — Cooperstown, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.